Assessment of the upper motor neuron in amyotrophic lateral sclerosis

Clinical Neurophysiology

Volumn 127, Issue 7, 2016, Pages 2643-2660

  Huynh, William ^a,b   Simon, Neil G ^c   Grosskreutz, Julian ^d   Turner, Martin R ^e   Vucic, Steve ^a   Kiernan, Matthew C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d JENA UNIVERSITY HOSPITAL   (Germany)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Imaging; Motor neuron disease; Transcranial magnetic stimulation; Upper motor neuron

Indexed keywords

BIOLOGICAL MARKER;

AMYOTROPHIC LATERAL SCLEROSIS; CONDITIONING; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; ELECTRONEUROLOGY; ELECTROPHYSIOLOGY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HOFFMANN REFLEX; HUMAN; MOTONEURON; MUSCLE ATROPHY; NERVE CELL DEGENERATION; NERVE CELL NETWORK; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLANTAR REFLEXE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PYRAMIDAL TRACT; REFLEX; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINAL REFLEX; TENDON REFLEX; TRANSCRANIAL MAGNETIC STIMULATION; DIAGNOSTIC IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; DIFFUSION TENSOR IMAGING; H-REFLEX; HUMANS; MAGNETIC RESONANCE IMAGING; MOTOR NEURONS; POSITRON-EMISSION TOMOGRAPHY; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84968732919     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2016.04.025     Document Type: Review

References (211)

1. Abe K., Fujimura H., Toyooka K., Hazama T., Hirono N., Yorifuji S., et al. Single-photon emission computed tomographic investigation of patients with motor neuron disease. Neurology 1993, 43:1569-1573.
2. Abe O., Yamada H., Masutani Y., Aoki S., Kunimatsu A., Yamasue H., et al. Amyotrophic lateral sclerosis: diffusion tensor tractography and voxel-based analysis. NMR Biomed 2004, 17:411-416.
3. Abrahams S., Goldstein L.H., Kew J.J., Brooks D.J., Lloyd C.M., Frith C.D., et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain 1996, 119(Pt 6):2105-2120.
4. Abrahams S., Goldstein L.H., Suckling J., Ng V., Simmons A., Chitnis X., et al. Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol 2005, 252:321-331.
5. Agosta F., Rocca M.A., Valsasina P., Sala S., Caputo D., Perini M., et al. A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 2009, 80:53-55.
6. Agosta F., Chio A., Cosottini M., De Stefano N., Falini A., Mascalchi M., et al. The present and the future of neuroimaging in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2010, 31:1769-1777.
7. Agosta F., Pagani E., Petrolini M., Caputo D., Perini M., Prelle A., et al. Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. AJNR Am J Neuroradiol 2010, 31:1457-1461.
8. Agosta F., Valsasina P., Absinta M., Riva N., Sala S., Prelle A., et al. Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis. Cereb Cortex 2011, 21:2291-2298.
9. Agosta F., Valsasina P., Riva N., Copetti M., Messina M.J., Prelle A., et al. The cortical signature of amyotrophic lateral sclerosis. PloS One 2012, 7:e42816.
10. Anzai E., Shiozawa Z., Shindo K., Tsunoda S., Koizumi K. Uchiyama G. Kaku Igaku 1990, 27:863-867.
11. Awiszus F., Feistner H. Abnormal EPSPs evoked by magnetic brain stimulation in hand muscle motoneurons of patients with amyotrophic lateral sclerosis. Electroencephalogr Clin Neurophysiol 1993, 89:408-414.
12. Awiszus F., Feistner H. Comparison of single motor unit responses to transcranial magnetic and peroneal nerve stimulation in the tibialis anterior muscle of patients with amyotrophic lateral sclerosis. Electroencephalogr Clin Neurophysiol 1995, 97:90-95.
13. Bae J.S., Ferguson M., Tan R., Mioshi E., Simon N., Burrell J., et al. Dissociation of structural and functional integrities of the motor system in amyotrophic lateral sclerosis and behavioral-variant frontotemporal dementia. J Clin Neurol 2016, 12:209-217.
14. Baek W.S., Desai N.P. ALS: pitfalls in the diagnosis. Pract Neurol 2007, 7:74-81.
15. Bak T.H., Chandran S. What wires together dies together: verbs, actions and neurodegeneration in motor neuron disease. Cortex 2012, 48:936-944.
16. Block W., Karitzky J., Traber F., Pohl C., Keller E., Mundegar R.R., et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol 1998, 55:931-936.
17. Bour L.J., Ongerboer de Visser B.W., Koelman J.H., Van Bruggen G.J., Speelman J.D. Soleus H-reflex tests in spasticity and dystonia: a computerized analysis. J Electromyogr Kinesiol 1991, 1:9-19.
18. Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., Del Tredici K. Amyotrophic lateral sclerosis-a model of corticofugal axonal spread. Nat Rev Neurol 2013, 9:708-714.
19. Brooks B.R. El Escorial World Federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on motor neuron diseases/amyotrophic lateral sclerosis of the world federation of neurology research group on neuromuscular diseases and the el escorial "clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994, 124:S96-S107.
20. Brooks B.R., Bushara K., Khan A., Hershberger J., Wheat J.O., Belden D., et al. Functional magnetic resonance imaging (fMRI) clinical studies in ALS-paradigms, problems and promises. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1(Suppl. 2):S23-S32.
21. Brooks B.R., Miller R.G., Swash M., Munsat T.L. World Federation of Neurology Research Group on motor neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1:293-299.
22. Brownell B., Oppenheimer D.R., Hughes J.T. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 1970, 33:338-357.
23. Buchthal F., Schmalbruch H. Contraction times of twitches evoked by H-reflexes. Acta Physiol Scand 1970, 80:378-382.
24. Burrell J.R., Kiernan M.C., Vucic S., Hodges J.R. Motor neuron dysfunction in frontotemporal dementia. Brain 2011, 134:2582-2594.
25. Burrell J.R., Halliday G.M., Kril J.J., Ittner L.M., Gotz J., Kiernan M.C., et al. The frontotemporal dementia-motor neuron disease continuum. Lancet 2016, 10.1016/S0140-6736(16)00737-6.
26. Cantello R., Gianelli M., Civardi C., Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 1992, 42:1951-1959.
27. Carrara G., Carapelli C., Venturi F., Ferraris M.M., Lequio L., Chio A., et al. A distinct MR imaging phenotype in amyotrophic lateral sclerosis: correlation between T1 magnetization transfer contrast hyperintensity along the corticospinal tract and diffusion tensor imaging analysis. AJNR Am J Neuroradiol 2012, 33:733-739.
28. Cervo A., Cocozza S., Sacca F., Giorgio S.M., Morra V.B., Tedeschi E., et al. The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis. Eur J Radiol 2015, 84:151-157.
29. Chan S., Shungu D.C., Douglas-Akinwande A., Lange D.J., Rowland L.P. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology 1999, 212:763-769.
30. Chan S., Kaufmann P., Shungu D.C., Mitsumoto H. Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron. Neuroimaging Clin N Am. 2003, 13:307-326.
31. Chang J.L., Lomen-Hoerth C., Murphy J., Henry R.G., Kramer J.H., Miller B.L., et al. A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology 2005, 65:75-80.
32. Chapman M.C., Jelsone-Swain L., Johnson T.D., Gruis K.L., Welsh R.C. Diffusion tensor MRI of the corpus callosum in amyotrophic lateral sclerosis. J Magn Reson Imaging 2014, 39:641-647.
33. Charcot J., Joffroy A. Deus cas d'atrophie musculaire progressive avec lesions de la substance grise et des faisceaux antéro-latérale. Arch Physiol 1869, 2:354-367.
34. Chen Z., Ma L. Grey matter volume changes over the whole brain in amyotrophic lateral sclerosis: a voxel-wise meta-analysis of voxel based morphometry studies. Amyotroph Lateral Scler 2010, 11:549-554.
35. Chio A., Traynor B.J. Motor neuron disease in 2014 biomarkers for ALS-in search of the promised land. Nat Rev Neurol 2015, (11):72-74.
36. Chio A., Pagani M., Agosta F., Calvo A., Cistaro A., Filippi M. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. Lancet Neurol 2014, 13:1228-1240.
37. Cistaro A., Valentini M.C., Chio A., Nobili F., Calvo A., Moglia C., et al. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging 2012, 39:251-259.
38. Cistaro A., Cuccurullo V., Quartuccio N., Pagani M., Valentini M.C., Mansi L. Role of PET and SPECT in the study of amyotrophic lateral sclerosis. Biomed Res Int 2014, 2014:237437.
39. Cosottini M., Giannelli M., Siciliano G., Lazzarotti G., Michelassi M.C., Del Corona A., et al. Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. Radiology 2005, 237:258-264.
40. Cosottini M., Giannelli M., Vannozzi F., Pesaresi I., Piazza S., Belmonte G., et al. Evaluation of corticospinal tract impairment in the brain of patients with amyotrophic lateral sclerosis by using diffusion tensor imaging acquisition schemes with different numbers of diffusion-weighting directions. J Comput Assist Tomogr 2010, 34:746-750.
41. Costa J., Swash M., de Carvalho M. Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review. Arch Neurol 2012, 69:1410-1416.
42. Cwik V.A., Hanstock C.C., Allen P.S., Martin W.R. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology 1998, 50:72-77.
43. da Rocha A.J., Oliveira A.S., Fonseca R.B., Maia A.C., Buainain R.P., Lederman H.M. Detection of corticospinal tract compromise in amyotrophic lateral sclerosis with brain MR imaging: relevance of the T1-weighted spin-echo magnetization transfer contrast sequence. AJNR Am J Neuroradiol 2004, 25:1509-1515.
44. Dalakas M.C., Hatazawa J., Brooks R.A., Di Chiro G. Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann Neurol 1987, 22:580-586.
45. de Carvalho M. Testing upper motor neuron function in amyotrophic lateral sclerosis: the most difficult task of neurophysiology. Brain 2012, 135:2581-2582.
46. de Carvalho M., Scotto M., Lopes A., Swash M. Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis. Muscle Nerve 2003, 28:630-633.
47. de Carvalho M., Dengler R., Eisen A., England J.D., Kaji R., Kimura J., et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008, 119:497-503.
48. Desiato M.T., Caramia M.D. Towards a neurophysiological marker of amyotrophic lateral sclerosis as revealed by changes in cortical excitability. Electroencephalogr Clin Neurophysiol 1997, 105:1-7.
49. Douaud G., Filippini N., Knight S., Talbot K., Turner M.R. Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain 2011, 134:3470-3479.
50. Drory V.E., Neufeld M.Y., Korczyn A.D. F-wave characteristics following acute and chronic upper motor neuron lesions. Electromyogr Clin Neurophysiol 1993, 33:441-446.
51. Drory V.E., Kovach I., Groozman G.B. Electrophysiologic evaluation of upper motor neuron involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2001, 2:147-152.
52. Eisen A., Weber M. Neurophysiological evaluation of cortical function in the early diagnosis of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1(Suppl 1):S47-S51.
53. Eisen A., Weber M. The motor cortex and amyotrophic lateral sclerosis. Muscle Nerve 2001, 24:564-573.
54. Eisen A., Pant B., Stewart H. Cortical excitability in amyotrophic lateral sclerosis: a clue to pathogenesis. Can J Neurol Sci 1993, 20:11-16.
55. Eisen A., Entezari-Taher M., Stewart H. Cortical projections to spinal motoneurons: changes with aging and amyotrophic lateral sclerosis. Neurology 1996, 46:1396-1404.
56. Eisen A., Nakajima M., Weber M. Electrophysiological studies of the corticomotoneuron in ALS. Rinsho shinkeigaku 1999, 39:99.
57. Ellis C.M., Simmons A., Andrews C., Dawson J.M., Williams S.C., Leigh P.N. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 1998, 51:1104-1109.
58. Ellis C.M., Suckling J., Amaro E., Bullmore E.T., Simmons A., Williams S.C., et al. Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS. Neurology 2001, 57:1571-1578.
59. Farrar M.A., Vucic S., Johnston H.M., Kiernan M.C. Corticomotoneuronal integrity and adaptation in spinal muscular atrophy. Arch Neurol 2012, 69:467-473.
60. Feiereisen P., Duchateau J., Hainaut K. Motor unit recruitment order during voluntary and electrically induced contractions in the tibialis anterior. Exp Brain Res 1997, 114:117-123.
61. Filippi M., Agosta F., Grosskreutz J., Benatar M., Kassubek J., Verstraete E., et al. Progress towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol 2015, 14:786-788.
62. Filippini N., Douaud G., Mackay C.E., Knight S., Talbot K., Turner M.R. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology 2010, 75:1645-1652.
63. Fisher M.A. F/M ratios in polyneuropathy and spastic hyperreflexia. Muscle Nerve 1988, 11:217-222.
64. Fisher R.J., Nakamura Y., Bestmann S., Rothwell J.C., Bostock H. Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking. Exp Brain Res 2002, 143:240-248.
65. Fisher K.M., Zaaimi B., Williams T.L., Baker S.N., Baker M.R. Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease. Brain 2012, 135:2849-2864.
66. Foerster B.R., Dwamena B.A., Petrou M., Carlos R.C., Callaghan B.C., Churchill C.L., et al. Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. Acad Radiol 2013, 20:1099-1106.
67. Foerster B.R., Welsh R.C., Feldman E.L. 25 years of neuroimaging in amyotrophic lateral sclerosis. Nat Rev Neurol 2013, 9:513-524.
68. Foerster B.R., Carlos R.C., Dwamena B.A., Callaghan B.C., Petrou M., Edden R.A., et al. Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis. Ann Clin Transl Neurol 2014, 1:107-114.
69. Funase K., Imanaka K., Nishihira Y. Excitability of the soleus motoneuron pool revealed by the developmental slope of the H-reflex as reflex gain. Electromyogr Clin Neurophysiol 1994, 34:477-489.
70. Funase K., Higashi T., Yoshimura T., Imanaka K., Nishihira Y. Evident difference in the excitability of the motoneuron pool between normal subjects and patients with spasticity assessed by a new method using H-reflex and M-response. Neurosci Lett 1996, 203:127-130.
71. Furtula J., Johnsen B., Frandsen J., Rodell A., Christensen P.B., Pugdahl K., et al. Upper motor neuron involvement in amyotrophic lateral sclerosis evaluated by triple stimulation technique and diffusion tensor MRI. J Neurol 2013, 260:1535-1544.
72. Geevasinga N., Menon P., Yiannikas C., Kiernan M.C., Vucic S. Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis. Eur J Neurol 2014, 21:1451-1457.
73. Geevasinga N., Menon P., Nicholson G.A., Ng K., Howells J., Kril J.J., et al. Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis. JAMA Neurol 2015, 72:1268-1274.
74. Geevasinga N., Menon P., Sue C.M., Kumar K.R., Ng K., Yiannikas C., et al. Cortical excitability changes distinguish the motor neuron disease phenotypes from hereditary spastic paraplegia. Eur J Neurol 2015, 22(826-31):e57-e58.
75. Giroud M., Walker P., Bernard D., Lemesle M., Martin D., Baudouin N., et al. Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis. Neurol Res 1996, 18:241-243.
76. Goodin D.S., Rowley H.A., Olney R.K. Magnetic resonance imaging in amyotrophic lateral sclerosis. Ann Neurol 1988, 23:418-420.
77. Govind V., Sharma K.R., Maudsley A.A., Arheart K.L., Saigal G., Sheriff S. Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy. PloS One 2012, 7:e35607.
78. Graham J.M., Papadakis N., Evans J., Widjaja E., Romanowski C.A., Paley M.N., et al. Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology 2004, 63:2111-2119.
79. Gredal O., Rosenbaum S., Topp S., Karlsborg M., Strange P., Werdelin L. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 1997, 48:878-881.
80. Grieve S.M., Menon P., Korgaonkar M.S., Gomes L., Foster S., Kiernan M.C., et al. Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS. Amyotroph Lateral Scler Frontotemporal Degener 2015, 17:85-92.
81. Grosskreutz J., Kaufmann J., Fradrich J., Dengler R., Heinze H.J., Peschel T. Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurol 2006, 6:17.
82. Han J., Ma L. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis. J Magn Reson Imaging 2010, 31:305-308.
83. Hanajima R., Ugawa Y., Terao Y., Ogata K., Kanazawa I. Ipsilateral cortico-cortical inhibition of the motor cortex in various neurological disorders. J Neurol Sci 1996, 140:109-116.
84. Hanstock C.C., Cwik V.A., Martin W.R. Reduction in metabolite transverse relaxation times in amyotrophic lateral sclerosis. J Neurol Sci 2002, 198:37-41.
85. Hardiman O., van den Berg L.H., Kiernan M.C. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 2011, 7:639-649.
86. Hartung V., Prell T., Gaser C., Turner M.R., Tietz F., Ilse B., et al. Voxel-based MRI intensitometry reveals extent of cerebral white matter pathology in amyotrophic lateral sclerosis. PloS One 2014, 9:e104894.
87. Higashi T., Funase K., Kusano K., Tabira T., Harada N., Sakakibara A., et al. Motoneuron pool excitability of hemiplegic patients: assessing recovery stages by using H-reflex and M response. Arch Phys Med Rehabil 2001, 82:1604-1610.
88. Hornberger M., Kiernan M.C. Emergence of an imaging biomarker for amyotrophic lateral sclerosis: is the end point near?. J Neurol Neurosurg Psychiatry 2016, 10.1136/jnnp-2015-312882.
89. Hultborn H., Meunier S., Morin C., Pierrot-Deseilligny E. Assessing changes in presynaptic inhibition of I a fibres: a study in man and the cat. J Physiol 1987, 389:729-756.
90. Huynh W., Lam A., Vucic S., Cheah B.C., Clouston P., Kiernan M.C. Corticospinal tract dysfunction and development of amyotrophic lateral sclerosis following electrical injury. Muscle Nerve 2010, 42:288-292.
91. Huynh W., Krishnan A.V., Vucic S., Lin C.S., Kiernan M.C. Motor cortex excitability in acute cerebellar infarct. Cerebellum 2013, 12:826-834.
92. Huynh W., Vucic S., Krishnan A.V., Lin C.S., Hornberger M., Kiernan M.C. Longitudinal plasticity across the neural axis in acute stroke. Neurorehabil Neural Repair 2013, 27:219-229.
93. Huynh W., Vucic S., Krishnan A.V., Lin C.S., Kiernan M.C. Exploring the evolution of cortical excitability following acute stroke. Neurorehabil Neural Repair 2016, 30:244-257.
94. Ince P.G., Evans J., Knopp M., Forster G., Hamdalla H.H., Wharton S.B., et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology. 2003, 60:1252-1258.
95. Iwata N.K., Aoki S., Okabe S., Arai N., Terao Y., Kwak S., et al. Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation. Neurology 2008, 70:528-532.
96. Iwata N.K., Kwan J.Y., Danielian L.E., Butman J.A., Tovar-Moll F., Bayat E., et al. White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 2011, 134:2642-2655.
97. Jacob S., Finsterbusch J., Weishaupt J.H., Khorram-Sefat D., Frahm J., Ehrenreich H. Diffusion tensor imaging for long-term follow-up of corticospinal tract degeneration in amyotrophic lateral sclerosis. Neuroradiology 2003, 45:598-600.
98. Jelsone-Swain L.M., Fling B.W., Seidler R.D., Hovatter R., Gruis K., Welsh R.C. Reduced interhemispheric functional connectivity in the motor cortex during rest in limb-onset amyotrophic lateral sclerosis. Front Syst Neurosci 2010, 4:158.
99. Kaufmann P., Mitsumoto H. Amyotrophic lateral sclerosis: objective upper motor neuron markers. Curr Neurol Neurosci Rep 2002, 2:55-60.
100. Kaufmann P., Pullman S.L., Shungu D.C., Chan S., Hays A.P., Del Bene M.L., et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 2004, 62:1753-1757.
101. Keil C., Prell T., Peschel T., Hartung V., Dengler R., Grosskreutz J. Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC Neurosci 2012, 13:141.
102. Kew J.J., Leigh P.N., Playford E.D., Passingham R.E., Goldstein L.H., Frackowiak R.S., et al. Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain 1993, 116(Pt 3):655-680.
103. Kiernan J.A., Hudson A.J. Frontal lobe atrophy in motor neuron diseases. Brain 1994, 117(Pt 4):747-757.
104. Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., et al. Amyotrophic lateral sclerosis. Lancet 2011, 377:942-955.
105. Kiers L., Cros D., Chiappa K.H., Fang J. Variability of motor potentials evoked by transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol 1993, 89:415-423.
106. Kleine B.U., Schelhaas H.J., van Elswijk G., de Rijk M.C., Stegeman D.F., Zwarts M.J. Prospective, blind study of the triple stimulation technique in the diagnosis of ALS. Amyotroph Lateral Scler 2010, 11:67-75.
107. Komissarow L., Rollnik J.D., Bogdanova D., Krampfl K., Khabirov F.A., Kossev A., et al. Triple stimulation technique (TST) in amyotrophic lateral sclerosis. Clin Neurophysiol 2004, 115:356-360.
108. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., et al. Corticocortical inhibition in human motor cortex. J Physiol 1993, 471:501-519.
109. Landau W.M., Clare M.H. The plantar reflex in man, with special reference to some conditions where the extensor response is unexpectedly absent. Brain 1959, 82:321-355.
110. Lawyer T., Netsky M.G. Amyotrophic lateral sclerosis. AMA Arch Neurol Psychiatry 1953, 69:171-192.
111. Lee M., Lance J., Burke D., Fitzpatrick R., Simon N.G., Kiernan M.C. Vibration-Induced H-Reflex Inhibition is Suppressed in ALS - A Biomarker for Upper Motor Neuron Dysfunction? 25th International ALS/MND Symposium 2014, Brussels, Belgium. first ed.
112. Ludolph A.C., Elger C.E., Bottger I.W., Kuttig A.G., Lottes G., Brune G.G. N-isopropyl-p-123I-amphetamine single photon emission computer tomography in motor neuron disease. Eur Neurol 1989, 29:255-260.
113. Luis M.L., Hormigo A., Mauricio C., Alves M.M., Serrao R. Magnetic resonance imaging in motor neuron disease. J Neurol 1990, 237:471-474.
114. Lule D., Diekmann V., Kassubek J., Kurt A., Birbaumer N., Ludolph A.C., et al. Cortical plasticity in amyotrophic lateral sclerosis: motor imagery and function. Neurorehabil Neural Repair 2007, 21:518-526.
115. Magistris M.R., Rosler K.M., Truffert A., Myers J.P. Transcranial stimulation excites virtually all motor neurons supplying the target muscle. A demonstration and a method improving the study of motor evoked potentials. Brain 1998, 121(Pt 3):437-450.
116. Magistris M.R., Rosler K.M., Truffert A., Landis T., Hess C.W. A clinical study of motor evoked potentials using a triple stimulation technique. Brain 1999, 122(Pt 2):265-279.
117. Mazzini L., Balzarini C., Gareri F., Brigatti M. H-reflex changes in the course of amyotrophic lateral sclerosis. Electroencephalogr Clin Neurophysiol 1997, 104:411-417.
118. Menon P., Kiernan M.C., Vucic S. Cortical dysfunction underlies the development of the split-hand in amyotrophic lateral sclerosis. PloS One 2014, 9:e87124.
119. Menon P., Geevasinga N., Yiannikas C., Howells J., Kiernan M.C., Vucic S. Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study. Lancet Neurol 2015, 14:478-484.
120. Menon P., Kiernan M.C., Vucic S. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS. Clin Neurophysiol 2015, 126:803-809.
121. Menon P., Geevasinga N., Yiannikas C., Kiernan M.C., Vucic S. Cortical contributions to the flail leg syndrome: Pathophysiological insights. Amyotroph Lateral Scler Frontotemporal Degener 2016 Feb, 18:1-8. 10.3109/21678421.2016.1145232.
122. Mezzapesa D.M., Ceccarelli A., Dicuonzo F., Carella A., De Caro M.F., Lopez M., et al. Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2007, 28:255-259.
123. Mezzapesa D.M., D'Errico E., Tortelli R., Distaso E., Cortese R., Tursi M., et al. Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. PloS One 2013, 8:e80748.
124. Mills K.R. Motor neuron disease. Studies of the corticospinal excitation of single motor neurons by magnetic brain stimulation. Brain 1995, 118(Pt 4):971-982.
125. Mills K.R., Nithi K.A. Corticomotor threshold is reduced in early sporadic amyotrophic lateral sclerosis. Muscle Nerve 1997, 20:1137-1141.
126. Mills K.R., Nithi K.A. Peripheral and central motor conduction in amyotrophic lateral sclerosis. J Neurol Sci 1998, 159:82-87.
127. Miscio G., Pisano F., Mora G., Mazzini L. Motor neuron disease: usefulness of transcranial magnetic stimulation in improving the diagnosis. Clin Neurophysiol 1999, 110:975-981.
128. Misiaszek J.E. The H-reflex as a tool in neurophysiology: its limitations and uses in understanding nervous system function. Muscle Nerve 2003, 28:144-160.
129. Mitsumoto H., Ulug A.M., Pullman S.L., Gooch C.L., Chan S., Tang M.X., et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 2007, 68:1402-1410.
130. Mohammadi B., Kollewe K., Samii A., Krampfl K., Dengler R., Munte T.F. Changes of resting state brain networks in amyotrophic lateral sclerosis. Exp Neurol 2009, 217:147-153.
131. Muller H.P., Turner M.R., Grosskreutz J., Abrahams S., Bede P., Govind V., et al. A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2016, 10.1136/jnnp-2015-311952.
132. Murphy J.M., Henry R.G., Langmore S., Kramer J.H., Miller B.L., Lomen-Hoerth C. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 2007, 64:530-534.
133. Nakajima M., Eisen A., Stewart H. Diverse abnormalities of corticomotoneuronal projections in individual patients with amyotrophic lateral sclerosis. Electroencephalogr Clin Neurophysiol 1997, 105:451-457.
134. Nihei K., McKee A.C., Kowall N.W. Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients. Acta Neuropathol 1993, 86:55-64.
135. Oba H., Araki T., Ohtomo K., Monzawa S., Uchiyama G., Koizumi K., et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 1993, 189:843-846.
136. Pagani M., Chio A., Valentini M.C., Oberg J., Nobili F., Calvo A., et al. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis. Neurology 2014, 83:1067-1074.
137. Peretti-Viton P., Azulay J.P., Trefouret S., Brunel H., Daniel C., Viton J.M., et al. MRI of the intracranial corticospinal tracts in amyotrophic and primary lateral sclerosis. Neuroradiology 1999, 41:744-749.
138. Pierrot-Deseilligny E., Burke D. The circuitry of the human spinal cord: its role in motor control and movement disorders 2005, 557-582. Cambridge University Press, Cambridge. first ed.
139. Pierrot-Deseilligny E., Burke D. The circuitry of the human spinal cord: Spinal and corticospinal mechanisms of movement 2012, Cambridge University Press, Cambridge. first ed.
140. Pioro E.P., Antel J.P., Cashman N.R., Arnold D.L. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994, 44:1933-1938.
141. Pohl C., Block W., Karitzky J., Traber F., Schmidt S., Grothe C., et al. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol 2001, 58:729-735.
142. Pohl C., Block W., Traber F., Schmidt S., Pels H., Grothe C., et al. Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. J Neurol Sci 2001, 190:21-27.
143. Pouget J., Trefouret S., Attarian S. Transcranial magnetic stimulation (TMS): compared sensitivity of different motor response parameters in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1(Suppl. 2):S45-S49.
144. Prout A.J., Eisen A.A. The cortical silent period and amyotrophic lateral sclerosis. Muscle Nerve 1994, 17:217-223.
145. Raynor E.M., Shefner J.M. Recurrent inhibition is decreased in patients with amyotrophic lateral sclerosis. Neurology 1994, 44:2148-2153.
146. Rocha A.J., Maia Júnior A.C. Is magnetic resonance imaging a plausible biomarker for upper motor neuron degeneration in amyotrophic lateral sclerosis/primary lateral sclerosis or merely a useful paraclinical tool to exclude mimic syndromes? A critical review of imaging applicability in clinical routine. Arquivos de neuro-psiquiatria 2012, 70:532-539.
147. Rooney W.D., Miller R.G., Gelinas D., Schuff N., Maudsley A.A., Weiner M.W. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 1998, 50:1800-1805.
148. Rosler K.M., Truffert A., Hess C.W., Magistris M.R. Quantification of upper motor neuron loss in amyotrophic lateral sclerosis. Clin Neurophysiol 2000, 111:2208-2218.
149. Rossini P.M., Berardelli A., Deuschl G., Hallett M., Maertens de Noordhout A.M., Paulus W., et al. Applications of magnetic cortical stimulation. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl 1999, 52:171-185.
150. Rule R.R., Suhy J., Schuff N., Gelinas D.F., Miller R.G., Weiner M.W. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5:141-149.
151. Sabatelli M., Zollino M., Luigetti M., Grande A.D., Lattante S., Marangi G., et al. Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS. Amyotroph Lateral Scler 2011, 12:278-282.
152. Sach M., Winkler G., Glauche V., Liepert J., Heimbach B., Koch M.A., et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004, 127:340-350.
153. Sage C.A., Van Hecke W., Peeters R., Sijbers J., Robberecht W., Parizel P., et al. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisited. Hum Brain Mapp 2009, 30:3657-3675.
154. Schoenfeld M.A., Tempelmann C., Gaul C., Kuhnel G.R., Duzel E., Hopf J.M., et al. Functional motor compensation in amyotrophic lateral sclerosis. J Neurol 2005, 252:944-952.
155. Schulte-Mattler W.J., Muller T., Zierz S. Transcranial magnetic stimulation compared with upper motor neuron signs in patients with amyotrophic lateral sclerosis. J Neurol Sci 1999, 170:51-56.
156. Shiozawa Z., Shindo K., Ohta E., Ohushi K., Nagamatsu M., Nagasaka T. A concise overview of recent breakthroughs in imaging of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1(Suppl 2):S3-S6.
157. Simon N.G., Kliot M. Diffusion weighted MRI and tractography for evaluating peripheral nerve degeneration and regeneration. Neural Regen Res 2014, 9:2122-2124.
158. Simon N.G., Turner M.R., Vucic S., Al-Chalabi A., Shefner J., Lomen-Hoerth C., et al. Quantifying disease progression in amyotrophic lateral sclerosis. Ann Neurol 2014, 76:643-657.
159. Simon N.G., Lin C.S.-Y., Lee M., Howells J., Vucic S., Burke D., et al. Segmental motoneuronal dysfunction is a feature of amyotrophic lateral sclerosis. Clin Neurophysiol 2015, 126:828-836.
160. Sivak S., Bittsansky M., Kurca E., Turcanova-Koprusakova M., Grofik M., Nosal V., et al. Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis. Neuroradiology 2010, 52:1079-1085.
161. Stagg C.J., Knight S., Talbot K., Jenkinson M., Maudsley A.A., Turner M.R. Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS. Neurology 2013, 80:610-615.
162. Stefan K., Kunesch E., Benecke R., Classen J. Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis. Ann Neurol 2001, 49:536-539.
163. Stephens B., Guiloff R.J., Navarrete R., Newman P., Nikhar N., Lewis P. Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study. J Neurol Sci 2006, 244:41-58.
164. Swash M. Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis?. J Neurol Neurosurg Psychiatry 2012, 83:659-662.
165. Tedeschi G., Trojsi F., Tessitore A., Corbo D., Sagnelli A., Paccone A., et al. Interaction between aging and neurodegeneration in amyotrophic lateral sclerosis. Neurobiol Aging 2012, 33:886-898.
166. Tessitore A., Esposito F., Monsurro M.R., Graziano S., Panza D., Russo A., et al. Subcortical motor plasticity in patients with sporadic ALS: an fMRI study. Brain Res Bull 2006, 69:489-494.
167. Thivard L., Pradat P.F., Lehericy S., Lacomblez L., Dormont D., Chiras J., et al. Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability. J Neurol Neurosurg Psychiatry 2007, 78:889-892.
168. Thorns J., Jansma H., Peschel T., Grosskreutz J., Mohammadi B., Dengler R., et al. Extent of cortical involvement in amyotrophic lateral sclerosis-an analysis based on cortical thickness. BMC Neurol 2013, 13:148.
169. Triggs W.J., Menkes D., Onorato J., Yan R.S., Young M.S., Newell K., et al. Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease. Neurology 1999, 53:605-611.
170. Turner M.R., Kiernan M.C. Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?. Amyotroph Lateral Scler 2012, 13:245-250.
171. Turner M.R., Leigh P.N. Positron emission tomography (PET)-its potential to provide surrogate markers in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1(Suppl 2):S17-S22.
172. Turner M.R., Osei-Lah A.D., Hammers A., Al-Chalabi A., Shaw C.E., Andersen P.M., et al. Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS. J Neurol Neurosurg Psychiatry 2005, 76:1279-1285.
173. Turner M.R., Rabiner E.A., Hammers A., Al-Chalabi A., Grasby P.M., Shaw C.E., et al. [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. Brain 2005, 128:896-905.
174. Turner M.R., Kiernan M.C., Leigh P.N., Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 2009, 8:94-109.
175. Turner M.R., Grosskreutz J., Kassubek J., Abrahams S., Agosta F., Benatar M., et al. Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol. 2011, 10:400-403.
176. Turner M.R., Agosta F., Bede P., Govind V., Lule D., Verstraete E. Neuroimaging in amyotrophic lateral sclerosis. Biomark Med 2012, 6:319-337.
177. Turner M.R., Hardiman O., Benatar M., Brooks B.R., Chio A., de Carvalho M., et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol 2013, 12:310-322.
178. Unrath A., Ludolph A.C., Kassubek J. Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study. J Neurol 2007, 254:1099-1106.
179. Uozumi T., Tsuji S., Murai Y. Motor potentials evoked by magnetic stimulation of the motor cortex in normal subjects and patients with motor disorders. Electroencephalogr Clin Neurophysiol 1991, 81:251-256.
180. van der Graaff M.M., Lavini C., Akkerman E.M., Majoie Ch.B., Nederveen A.J., Zwinderman A.H., et al. MR spectroscopy findings in early stages of motor neuron disease. AJNR Am J Neuroradiol 2010, 31:1799-1806.
181. Van Gijn J. The Babinski sign and the pyramidal syndrome. J Neurol Neurosurg Psychiatry 1978, 41:865-873.
182. Van Laere K., Vanhee A., Verschueren J., De Coster L., Driesen A., Dupont P., et al. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study. JAMA Neurol 2014, 71:553-561.
183. 18F-FDG brain PET discriminant analysis methods in the Diagnosis of amyotrophic lateral sclerosis. J Nucl Med 2016, 10.2967/jnumed.115.166272.
184. Verstraete E., Foerster B.R. Neuroimaging as a new diagnostic modality in amyotrophic lateral sclerosis. Neurotherapeutics 2015, 12:403-416.
185. Verstraete E., van den Heuvel M.P., Veldink J.H., Blanken N., Mandl R.C., Hulshoff Pol H.E., et al. Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study. PloS One 2010, 5:e13664.
186. Verstraete E., Veldink J.H., Hendrikse J., Schelhaas H.J., van den Heuvel M.P., van den Berg L.H. Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2012, 83:383-388.
187. Vucic S., Kiernan M.C. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain 2006, 129:2436-2446.
188. Vucic S., Kiernan M.C. Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007, 78:849-852.
189. Vucic S., Kiernan M.C. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis. Clin Neurophysiol 2008, 119:1088-1096.
190. Vucic S., Kiernan M.C. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology. Handbook of Clinical Neurology 2013, 116:561-575. P.J. Vinken, G.W. Bruyn (Eds.).
191. Vucic S., Howells J., Trevillion L., Kiernan M.C. Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve 2006, 33:477-486.
192. Vucic S., Nicholson G.A., Kiernan M.C. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 2008, 131:1540-1550.
193. Vucic S., Cheah B.C., Kiernan M.C. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis. Exp Neurol 2009, 220:177-182.
194. Vucic S., Cheah B.C., Yiannikas C., Vincent A., Kiernan M.C. Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia. Brain 2010, 133:2727-2733.
195. Vucic S., Nicholson G.A., Kiernan M.C. Cortical excitability in hereditary motor neuronopathy with pyramidal signs: comparison with ALS. J Neurol Neurosurg Psychiatry 2010, 81:97-100.
196. Vucic S., Winhammar J.M., Rowe D.B., Kiernan M.C. Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers. Clin Neurophysiol 2010, 121:1781-1785.
197. Vucic S., Cheah B.C., Yiannikas C., Kiernan M.C. Cortical excitability distinguishes ALS from mimic disorders. Clin Neurophysiol 2011, 122:1860-1866.
198. Vucic S., Lin C.S., Cheah B.C., Murray J., Menon P., Krishnan A.V., et al. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis. Brain 2013, 136:1361-1370.
199. Vucic S., Ziemann U., Eisen A., Hallett M., Kiernan M.C. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. J Neurol Neurosurg Psychiatry 2013, 84:1161-1170.
200. Walhout R., Westeneng H.J., Verstraete E., Hendrikse J., Veldink J.H., van den Heuvel M.P., et al. Cortical thickness in ALS: towards a marker for upper motor neuron involvement. J Neurol Neurosurg Psychiatry 2015, 86:288-294.
201. Weber M., Eisen A. Peristimulus time histograms (PSTHs)-a marker for upper motor neuron involvement in ALS?. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1(Suppl. 2):S51-S56.
202. Weber M., Eisen A., Nakajima M. Corticomotoneuronal activity in ALS: changes in the peristimulus time histogram over time. Clin Neurophysiol 2000, 111:169-177.
203. Wong J.C., Concha L., Beaulieu C., Johnston W., Allen P.S., Kalra S. Spatial profiling of the corticospinal tract in amyotrophic lateral sclerosis using diffusion tensor imaging. J Neuroimaging 2007, 17:234-240.
204. Yagishita A., Nakano I., Oda M., Hirano A. Location of the corticospinal tract in the internal capsule at MR imaging. Radiology 1994, 191:455-460.
205. Yokota T., Yoshino A., Inaba A., Saito Y. Double cortical stimulation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1996, 61:596-600.
206. Zanette G., Tamburin S., Manganotti P., Refatti N., Forgione A., Rizzuto N. Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis. J Neurol 2002, 249:1723-1728.
207. Zanette G., Tamburin S., Manganotti P., Refatti N., Forgione A., Rizzuto N. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis. Clin Neurophysiol 2002, 113:1688-1697.
208. Zhang Y., Schuff N., Woolley S.C., Chiang G.C., Boreta L., Laxamana J., et al. Progression of white matter degeneration in amyotrophic lateral sclerosis: A diffusion tensor imaging study. Amyotroph Lateral Scler 2011, 12:421-429.
209. Zhu W., Fu X., Cui F., Yang F., Ren Y., Zhang X., et al. ALFF Value in Right parahippocampal gyrus acts as a potential marker monitoring amyotrophic lateral sclerosis progression: a neuropsychological, voxel-based morphometry, and resting-state functional MRI study. J Mol Neurosci 2015, 57:106-113.
210. Ziemann U., Netz J., Szelenyi A., Homberg V. Spinal and supraspinal mechanisms contribute to the silent period in the contracting soleus muscle after transcranial magnetic stimulation of human motor cortex. Neurosci Lett 1993, 156:167-171.
211. Ziemann U., Winter M., Reimers C.D., Reimers K., Tergau F., Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation. Neurology 1997, 49:1292-1298.